Navigation Links
Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
Date:1/24/2013

MOUNTAIN VIEW, Calif., Jan. 24, 2013 /PRNewswire/ -- Medical Devices 2013: A Frost & Sullivan Executive MindXchange takes place March 10-12, 2013, at the Hilton San Diego Resort & Spa in San Diego, Calif. Participants will gain insight into the future of medical technology and healthcare delivery as they engage with other seasoned medical device executives driving the future of healthcare, as well as their company's innovation and business strategy.

Topics covered at this event include: Three Big Predictions: Healthcare 2025 – Personalization, Without PCP; Savvy Partnering for Innovation; Developing Innovative IP Strategies in a Global Economy; Mapping the Innovation Maturity Curve and mHealth: At the Forefront of Future Medicine. The valuable takeaways participants receive are very practical, and ready for immediate implementation.

"The Frost & Sullivan Executive MindXchange is one of the most uniquely designed and well thought out programs I have attended," said ConvaTec Global Government Affairs and Health Policy Vice President, Joseph Rolley . "The learning comes not just in the form of traditional lectures, but from audience participation and sharing of ideas and experiences."

The high-level program will be beneficial to senior-level executives, particularly those in C-level and vice president positions involved with; business development, government affairs & reimbursement, intellectual property, medical affairs, marketing, healthcare strategy, product development, QA, sales, strategic planning, technology assessment and commercialization, amongst others.

The influential keynote speakers at this event include:

Jim Hollingshead , Chief Strategy Officer and President of the Ventures and Initiatives Strategic Business Unit at ResMed, who will speak on mapping success in an outcomes-driven healthcare environment. The key takeaways provide insights into how outcomes-driven medicine influences go-to-market strategy for medical devices, leveraging medical research to inform and reset payer agendas, and creating compliance systems to align with personalized medicine.

Megan Moynahan , Assistant Director for Technology and Innovation from the Office of the Center Director at the Center for Devices and Radiological Health, (FDA) will address if the FDA can spur innovation. As stated by Moynahan, to handle truly innovative products against the vast tide of typical products it regulates, the FDA needs to cultivate both an "innovation mindset" and a "production mindset" – two opposing internal cultures that give rise to different processes and practices. The opposing cultures of "production" and "innovation" can co-exist in an organization, but only a thriving culture of innovation at the FDA will bring about the kind of transformative change needed to address long-standing trends.

Joe Kiani , Chairman and CEO at Masimo Corporation, will speak to the mounting cost pressures and rising healthcare inflation. According to Kiani, there is a recipe for "doing the right thing," which can protect patients, fuel innovation and reduce costs in our healthcare system.

Additional event highlights include "The Vino Voyage," where executive attendees will get acquainted over a wine tasting luncheon while cruising the San Diego harbor.  Attendees will participate in a unique event format of two-way dialogue and debate, while taking in the breathtaking location. Just seven miles from downtown, the Hilton San Diego Hotel sits on 18 acres of recreational paradise. The hotel also boasts an award-winning executive Chef and banquet team.

Click here to register for Medical Devices 2013 or visit: www.frost.com/dev. For more information, please email: events.us@frost.com. Also, feel free to join the conversation on Twitter through #DEV13.

About Frost & Sullivan   

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. 

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.  
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible.  This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.  

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.

Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?  

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing" 

Register:        Gain access to visionary innovation

Contact:
Mireya Espinoza
Corporate Communications – North America
P: 210.247.3870
E: mireya.espinoza@frost.com

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the ... Cardiology Devices segment is likely to create absolute $ opportunity ... over 2017. By the end of 2027, Cardiology Devices segment ... 700 Mn, expanding at a CAGR of 18.4% over the ... Asia Pacific reprocessed medical devices market in terms ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... Hollywood, Fl (PRWEB) , ... April 25, 2017 , ... ... than Memorial Regional Hospital, according to a special report in the May issue of ... Hospital its highest quality ranking for results achieved during and after coronary bypass ...
(Date:4/25/2017)... Marietta, GA (PRWEB) , ... April 25, 2017 ... ... implant and instrument solutions, announces the continuation of its strategic partnership with and ... surgeons in developing nations in the safe and effective management of complex spine ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The Santana Telehealth ... ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on April 23 ... Project for using telemedicine to improve the lives of the poor and underserved in ...
Breaking Medicine News(10 mins):